{"id":11479,"date":"2021-06-03T18:28:29","date_gmt":"2021-06-03T16:28:29","guid":{"rendered":"https:\/\/iabnetz.de\/?post_type=publikationen&#038;p=11479"},"modified":"2025-11-14T22:00:43","modified_gmt":"2025-11-14T21:00:43","slug":"modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pal-4","status":"publish","type":"page","link":"https:\/\/relaunch.iabnetz.com\/en\/publikationen\/weitere-veroeffentlichungen\/modified-constraint-induced-movement-therapy-or-bimanual-occupational-therapy-following-injection-of-botulinum-toxin-a-to-improve-bimanual-performance-in-young-children-with-hemiplegic-cerebral-pal-4\/","title":{"rendered":"Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation: Bjornson K et al."},"content":{"rendered":"<p><span class=\"a\">Pediatrics <\/span><span class=\"a\">. 2007 July ; 120(1): 49-58.<\/span><\/p>\n<div class=\"ff6\">\n<div class=\"ff7\"><span class=\"a\">\u00a0<\/span><\/div>\n<\/div>\n<div>Authors:<\/div>\n<div class=\"ff11\">\n<div class=\"ff6\">\n<div class=\"ff5\"><span class=\"a\">Kristie Bjornson, PhD, PT\u00a0\u00a0<\/span><span class=\"a\">a<\/span><span class=\"a\">,<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">Ross Hays, MD\u00a0\u00a0<\/span><span class=\"a\">b<\/span><span class=\"a\">,<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">Cathy Graubert, PT\u00a0\u00a0<\/span><span class=\"a\">a<\/span><span class=\"a\">,<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">Robert Price, MS\u00a0\u00a0<\/span><span class=\"a\">b<\/span><span class=\"a\">,<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">Francine Won, PT\u00a0\u00a0<\/span><span class=\"a\">a<\/span><span class=\"a\">,<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">John F. McLaughlin, MD\u00a0\u00a0<\/span><span class=\"a\">c<\/span><span class=\"a\">, and<\/span><\/div>\n<div class=\"ff5\"><span class=\"a\">Morty Cohen, RPh\u00a0\u00a0<\/span><span class=\"a\">a<\/span><\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<div class=\"ff4\">Author Details:<\/div>\n<div>\n<div class=\"ff4\">\n<div class=\"ff7\"><span class=\"a\">a\u00a0\u00a0<\/span><span class=\"a\">\u00a0Children\u2019s Hospital and Regional Medical Center,\u00a0Seattle Washington<\/span><\/div>\n<div class=\"ff7\"><span class=\"a\">b\u00a0 \u00a0<\/span><span class=\"a\">Rehabilitation Medicine, University of\u00a0Washington, Seattle, Washington<\/span><\/div>\n<div class=\"ff7\"><span class=\"a\">c\u00a0 \u00a0<\/span><span class=\"a\">Pediatrics, University of Washington, Seattle, Washington<\/span><\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<div>\n<p><a href=\"https:\/\/www.academia.edu\/23321331\/Botulinum_Toxin_for_Spasticity_in_Children_With_Cerebral_Palsy_A_Comprehensive_Evaluation?email_work_card=title\" target=\"_blank\" rel=\"noopener noreferrer\">Please click here!<\/a><\/p>\n<\/div>\n<\/div>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Abstract<br \/>\nBACKGROUND \u2014 Spasticity is a prevalent disabling clinical symptom for children with cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy was first reported in 1993. Botulinum toxin provides a focal, controlled muscle weakness with reduction in spasticity. Interpretation of the literature is difficult due to the paucity of reliable measures of spasticity and challenges with measuring meaningful functional changes in children with disabilities &#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":30426,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-11479","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=11479"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11479\/revisions"}],"predecessor-version":[{"id":30613,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/11479\/revisions\/30613"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30426"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=11479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}